CTSNet and the Society of Cardiovascular Anesthesiologists collaborated to host a live webinar on Monday, April 27, on cardiac surgery during COVID-19: ECMO, transplants, elective cases, and the future.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Mechanical circulatory assistance
Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes
April 16, 2020
The UNOS donor heart allocation system was revised in 2018, giving priority to patients on inpatient mechanical circulatory support (MCS). Patients admitted with heart failure-associated cardiogenic shock were tracked for the frequency of use of mechanical circulatory support before and after implementation of this change. In non-transplant center
In Situ Expansion, Differentiation and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid
April 2, 2020
Quite refreshing well-written experimental paper leaving promises of artificial organoids.
February 20, 2020
In this Giants of Cardiothoracic Surgery interview, Joel Dunning speaks with Oscar Howard “Bud” Frazier about his career and experience with mechanical hearts.
American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation Guidelines on Selected Topics in Mechanical Circulatory Support
January 30, 2020
The American Association for Thoracic Surgery and International Society for Heart and Lung Transplantation provide a consensus guidelines document on ten important aspects in mechanical circulatory support. These include:
January 22, 2020
This study investigated the impact of preoperative levosimendan administration in patients undergoing LVAD implantation. The authors report on outcomes of patients who received preoperative optimization with levosimendan (n=58) versus patients optimized without a Calcium-sensitizer (n=27).
January 14, 2020
Capoccia and Maybauer performed a system review of 29 publications related to the use of ECMO in aortic surgery and aortic dissection. A total of 194 patients who had been treated with ECMO support were identified, with a survival rate of 39.7% (77/194).
December 16, 2019
This video demonstrates how Dr David Morales implants a HeartMate 3™ and the various strategies used to manage the technical challenges of implanting the device in a 10-year-old, 26.7 kg, patient.
December 13, 2019
The authors analyzed the outcomes of the continuous-flow left ventricular assist devices. The study includes 105 patients supported with HM2 (N=54), HM3 (N=25), and HW (N-26). Eighteen-month data suggested that HM3 had a better prognostic and adverse-event profile over other devices.
December 4, 2019
Succinct commentary on the challenge of vascular access in ECMO circuits on the occasion of a manuscript on a novel design of a multi-access adaptor.